Suchergebnisse
Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza
Shares of Biogen BIIB rose 2% on Monday after the company announced that the FDA approved a higher dose of its blockbuster spinal muscular atrophy (SMA) drug Spinraza.
The new dosing regimen
AVGO's Gross Margin Contracts Sequentially: Is Growth Getting Harder?
Broadcom’s AVGO gross margin has contracted sequentially in the trailing four quarters. In the first quarter of fiscal 2026, the company reported a gross margin of 77% compared with 77.9% reported
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), a passively managed exchange
Countdown to Neogen (NEOG) Q3 Earnings: Wall Street Forecasts for Key Metrics
In its upcoming report, Neogen (NEOG) is predicted by Wall Street analysts to post quarterly earnings of $0.04 per share, reflecting a decline of 60% compared to the same period last year
Shell Plans Significant Investment Surge in Egypt's Gas Sector
Shell plc SHEL is reportedly planning to increase its investments in Egypt’s energy sector, demonstrating a strong commitment to the country’s efforts to boost natural gas production capabilities
NVIDIA Bets Big on Industrial Revolution 4.0: Outlook Swells
Investors wondering what NVIDIA’s (NASDAQ: NVDA) AI endgame is should consider Industrial Revolution 4.0 as the answer. Some may say it's already underway, but the reality is that the full potential
Oracle's NetSuite Division in Focus: Will it Boost Revenue Growth?
Oracle's ORCL NetSuite division delivered a steady performance in the third quarter of fiscal 2026, but its pace of expansion raises the question of whether the cloud ERP unit can pick up speed and
Constellation Brands' Q4 Earnings Beat, Sales Fall in Wine & Spirits Unit
Constellation Brands, Inc. STZ reported fourth-quarter fiscal 2026 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. The company’s sales and earnings declined year
Rio Tinto Aktie: Boron-Milliarden winken
Rio Tinto trennt sich von einem strategisch bedeutsamen Erbe: Die Borax-Mine in Kalifornien —…
Der Beitrag Rio Tinto Aktie: Boron-Milliarden winken erschien zuerst auf kapitalmarktexperten.de.
Quell
Johnson Controls International plc
WKN: A2AQCA / Symbol: JCI / Name: Johnson Controls / Aktie / Fahrzeuge & Fahrzeugteile / Large Cap /
Maven Brands Inc.
WKN: A3C6JH / Name: Maven Brands / Aktie / Pharmazeutika / Micro Cap /
Trading Theon International Plc
Trading Theon International Plc
Trading Tata Motors DVR
Trading Tata Motors DVR
Worthington Steel's Q3 Earnings Miss Estimates, Sales up Y/Y
Worthington Steel, Inc. WS reported adjusted earnings of 27 cents per share for the third quarter of fiscal 2026, missing the Zacks Consensus Estimate of 47 cents. It had posted adjusted earnings of
Consumer Confidence Climbs But Economic Woes Remain: 4 Utility Picks
Americans remain confident about the economy amid inflationary pressure and a sharp decline in job openings and hiring. A surge in gasoline prices also added to the pressure. Yet, consumer
Cisco's Gross Margin Contracts Sequentially: Is Growth Getting Harder?
Cisco Systems’ CSCO gross margin has contracted sequentially over the trailing four quarters. In the second quarter of fiscal 2026, CSCO reported a non-GAAP gross margin of 67.5% compared with 68.1%
Unlocking Q1 Potential of Delta (DAL): Exploring Wall Street Estimates for Key Metrics
In its upcoming report, Delta Air Lines (DAL) is predicted by Wall Street analysts to post quarterly earnings of $0.63 per share, reflecting an increase of 37% compared to the same period last
RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo Syndrome
Shares of Ultragenyx Pharmaceutical RARE rose 5% after the company announced that the FDA has accepted its resubmitted biologics license application (BLA) seeking accelerated approval for AAV gene
Likely Sector ETF & Stock Winners From March Jobs Report
U.S. non-farm payrolls increased a seasonally adjusted 178,000 in March, marking a sharp reversal from the 133,000 drop in February and better than the Dow Jones consensus estimate for 59,000, as




